[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Peter S. Dragovich<\/i><\/u><\/presenter>. Genentech, Inc., South San Francisco, CA","CSlideId":"","ControlKey":"2431a4ef-5e32-49c4-97d5-c8152d81f80a","ControlNumber":"245","DisclosureBlock":"&nbsp;<b>&nbsp;P.S. Dragovich:<\/b>  ; F. Hoffmann-La Roche. ; Genentech. ; Johnson and Johnson. ; Pfizer Inc..","End":"4\/14\/2023 4:46:00 PM","HasWebcast":null,"Highlights":[],"Id":"143","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Peter Dragovich, PhD","PresenterKey":"6ad503fb-b34e-4d44-8a56-418d703b0b1a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 4:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Peter S. Dragovich<\/i><\/u><\/presenter>. Genentech, Inc., SOUTH SAN FRANCISCO, CA","CSlideId":"","ControlKey":"52d77dc6-a5ad-48ee-aec8-51ca73dfbfc8","ControlNumber":"10275","DisclosureBlock":"<b>&nbsp;P. S. Dragovich, <\/b> <br><b>F. Hoffmann-La Roche<\/b> S, S, S. <br><b>Genentech<\/b> E, E, E. <br><b>Johnson and Johnson<\/b> E, E, E. <br><b>Pfizer Inc.<\/b> S, S, S.","End":"4\/14\/2023 4:46:00 PM","HasWebcast":null,"Highlights":[],"Id":"9029","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Peter Dragovich, PhD","PresenterKey":"6ad503fb-b34e-4d44-8a56-418d703b0b1a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 4:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Peter S. Dragovich<\/i><\/u><\/presenter>. Genentech, Inc., South San Francisco, CA","CSlideId":"","ControlKey":"23b92ba6-718b-42a1-9a26-8c8228d7d04b","ControlNumber":"506","DisclosureBlock":"<b>&nbsp;P. S. Dragovich, <\/b> <br><b>F. Hoffmann-La Roche<\/b> S. <br><b>Genentech<\/b> E. <br><b>Johnson and Johnson<\/b> E. <br><b>Pfizer Inc.<\/b> S.","End":"4\/14\/2023 5:06:00 PM","HasWebcast":null,"Highlights":[],"Id":"265","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Peter Dragovich, PhD","PresenterKey":"6ad503fb-b34e-4d44-8a56-418d703b0b1a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Recent progress in the optimization of antibody-drug conjugates as novel cancer therapies","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 4:46:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Recent progress in the optimization of antibody-drug conjugates as novel cancer therapies","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"e9b3c4f8-cb9d-4714-9e8b-321550bb5d6f","ControlNumber":"8635","DisclosureBlock":"","End":"4\/14\/2023 5:15:00 PM","HasWebcast":null,"Highlights":[],"Id":"1100","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 5:06:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Marc I. Damelin<\/i><\/u><\/presenter>. Mersana Therapeutics, Inc., Cambridge, MA","CSlideId":"","ControlKey":"129d4b9f-3cb1-4f24-b7a4-17f3adb73032","ControlNumber":"1355","DisclosureBlock":"","End":"4\/14\/2023 5:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"485","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Marc Damelin, PhD","PresenterKey":"ec4c94c1-bfef-4971-8a6d-b98478b22c07","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Immunostimulatory payloads and novel technologies for antibody-drug conjugates","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 5:15:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Immunostimulatory payloads and novel technologies for antibody-drug conjugates","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"63da05ff-db35-47f7-9cad-48bba77e8127","ControlNumber":"8636","DisclosureBlock":"","End":"4\/14\/2023 5:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"1101","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 5:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Adrian D. Hobson<\/i><\/u><\/presenter>. AbbVie Inc., Worcester, MA","CSlideId":"","ControlKey":"9e5d0949-cc5a-4cbd-b6ee-125c4aec0176","ControlNumber":"2312","DisclosureBlock":"","End":"4\/14\/2023 6:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"662","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Adrian Hobson, PhD","PresenterKey":"066f9dad-411e-41bf-9d36-a9f059cb4b2d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Considerations for non-oncology antibody-drug conjugates","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 5:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Considerations for non-oncology antibody-drug conjugates","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"38e40e37-70a4-497c-b08d-243dd88f37fb","ControlNumber":"8637","DisclosureBlock":"","End":"4\/14\/2023 6:15:00 PM","HasWebcast":null,"Highlights":[],"Id":"1102","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 14 2023  4:45PM","SessionId":"117","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 1 of 3: The Next Generation of Antibody Drug Conjugates","ShowChatLink":"false","Start":"4\/14\/2023 6:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]